Just published ‼️
10 recommendations for marketing authorisation holders, wholesalers, distributors or manufacturers of #medicines 💊 to prevent and manage medicine #shortages and their impact. 👇
https://www.ema.europa.eu/en/news/guidance-industry-prevent-mitigate-medicine-shortages
🐦🔗: https://n.respublicae.eu/EMA_News/status/1658849848177598465
@EMA_News
Not the EMA's fault but ecommendations are cute yet totally insufficient.
What must be addressed is the risk of generics' drug substances being produced
1 - by 1-2 manuctures only
2 - these manufacturers being located in one region of the world and or by one cooperation only.
Will this mean rising costs?
Absolutely.
But /this/ is the task at hand:
Telling people the truth that if they want to drastically reduce shortages, manufacturing will be more expensive.